Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma

Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T13:34:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-25T13:25:42.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T13:43:09.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T14:27:37.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 entry was added to the study record history, updating the version history. The previous Revision: v3.6.6 entry was removed.
    Difference
    0.1%
    Check dated 2026-09-20T20:20:03.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page's revision history shows a new entry: Revision: v3.6.6. The previous revision, v3.6.5, was removed, indicating a minor site update to the study record history.
    Difference
    0.1%
    Check dated 2026-08-30T21:58:49.000Z thumbnail image

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma

Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.